Ken Uekawa

2.0k total citations · 1 hit paper
46 papers, 1.5k citations indexed

About

Ken Uekawa is a scholar working on Neurology, Neurology and Physiology. According to data from OpenAlex, Ken Uekawa has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 13 papers in Neurology and 10 papers in Physiology. Recurrent topics in Ken Uekawa's work include Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Neurological Disease Mechanisms and Treatments (9 papers) and Intracranial Aneurysms: Treatment and Complications (8 papers). Ken Uekawa is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Neurological Disease Mechanisms and Treatments (9 papers) and Intracranial Aneurysms: Treatment and Complications (8 papers). Ken Uekawa collaborates with scholars based in Japan and United States. Ken Uekawa's co-authors include Yu Hasegawa, Shokei Kim‐Mitsuyama, Nobutaka Koibuchi, Kensuke Toyama, Takashi Nakagawa, Daisuke Sueta, Mingjie Ma, Bo-Wen Lin, Hiroaki Kusaka and Tetsuji Katayama and has published in prestigious journals such as Nature Communications, Nature Neuroscience and PLoS ONE.

In The Last Decade

Ken Uekawa

45 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice

2014 336 citations Bo-Wen Lin, Nobutaka Koibuchi et al. Cardiovascular Diabetology profile →

Peers

Ken Uekawa

NEURO

EDM

PHYSI

CCM

Paulo W. Pires United States

Kensuke Toyama Japan

Matthew Mitschelen United States

Kana Tsukuda Japan

Nobukazu Miyamoto Japan

Tripti Gautam United States

Prasad V. G. Katakam United States

Izumi Harukuni United States

Xunde Xian China

Jean‐Marie Sérot France

Paulo W. Pires United States

Ken Uekawa

327 ×0.7

NEURO

313 ×0.8

EDM

371 ×1.0

353 ×1.0

PHYSI

329 ×1.3

CCM

Citations per year, relative to Ken Uekawa Ken Uekawa (= 1×) peers Paulo W. Pires

Countries citing papers authored by Ken Uekawa

Since Specialization

Citations

This map shows the geographic impact of Ken Uekawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Uekawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Uekawa more than expected).

Fields of papers citing papers by Ken Uekawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Uekawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Uekawa. The network helps show where Ken Uekawa may publish in the future.

Co-authorship network of co-authors of Ken Uekawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Uekawa. A scholar is included among the top collaborators of Ken Uekawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Uekawa. Ken Uekawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Uekawa, Ken, Antoine Anfray, Sung Ji Ahn, et al.. (2024). tPA supplementation preserves neurovascular and cognitive function in Tg2576 mice. Alzheimer s & Dementia. 20(7). 4572–4582. 1 indexed citations

Uekawa, Ken, et al.. (2024). Perivascular macrophages in cerebrovascular diseases. Experimental Neurology. 374. 114680–114680. 6 indexed citations

Shinojima, Naoki, Shigetoshi Yano, Hiroyo Mabe, et al.. (2024). Long-term outcomes of multidisciplinary treatment combining surgery and stereotactic radiotherapy with Novalis for craniopharyngioma. Journal of Clinical Neuroscience. 120. 138–146. 1 indexed citations

Shinojima, Naoki, Yutaka Ueda, Hiroyo Mabe, et al.. (2023). Two children with lymphocytic hypophysitis presenting with positive anti-rabphilin-3A antibody. Endocrine Journal. 70(7). 703–709. 2 indexed citations

Uekawa, Ken, Yorito Hattori, Sung Ji Ahn, et al.. (2023). Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress. Molecular Neurodegeneration. 18(1). 73–73. 40 indexed citations

Uekawa, Ken, et al.. (2023). Pretreatment with Clodronate Improved Neurological Function by Preventing Reduction of Posthemorrhagic Cerebral Blood Flow in Experimental Subarachnoid Hemorrhage. Neurocritical Care. 39(1). 207–217. 6 indexed citations

Uekawa, Ken, Yasuyuki Kaku, Hiroaki Matsuzaki, et al.. (2020). Intracranial and extracranial multiple arterial dissecting aneurysms in rheumatoid arthritis: A case report. Interventional Neuroradiology. 27(2). 212–218. 4 indexed citations

Park, Laibaik, Karin Hochrainer, Yorito Hattori, et al.. (2020). Tau induces PSD95–neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration. Nature Neuroscience. 23(9). 1079–1089. 79 indexed citations

Kawano, Takayuki, Yuki Ohmori, Yasuyuki Kaku, et al.. (2020). Hemodynamic study about cortical hyperintensity belt sign after direct bypass surgery for moyamoya disease. Journal of Clinical Neuroscience. 74. 124–129. 3 indexed citations

10.

Kobayashi, Mariko, Corinne Benakis, Corey J. Anderson, et al.. (2019). AGO CLIP Reveals an Activated Network for Acute Regulation of Brain Glutamate Homeostasis in Ischemic Stroke. Cell Reports. 28(4). 979–991.e6. 19 indexed citations

11.

Koizumi, Kenzo, Yorito Hattori, Sung Ji Ahn, et al.. (2018). Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function. Nature Communications. 9(1). 3816–3816. 114 indexed citations

12.

Uekawa, Ken, Kenzo Koizumi, Jason Hwang, et al.. (2016). Obligatory Role of EP1 Receptors in the Increase in Cerebral Blood Flow Produced by Hypercapnia in the Mice. PLoS ONE. 11(9). e0163329–e0163329. 7 indexed citations

13.

Hasegawa, Yu, Hidenori Suzuki, Takashi Nakagawa, et al.. (2016). Assessment of the Correlations Between Brain Weight and Brain Edema in Experimental Subarachnoid Hemorrhage. Acta neurochirurgica. Supplementum. 121. 89–92. 1 indexed citations

14.

Hasegawa, Yu, Hidenori Suzuki, Ken Uekawa, Takayuki Kawano, & Shokei Kim‐Mitsuyama. (2015). Characteristics of Cerebrovascular Injury in the Hyperacute Phase After Induced Severe Subarachnoid Hemorrhage. Translational Stroke Research. 6(6). 458–466. 31 indexed citations

15.

Toyama, Kensuke, Nobutaka Koibuchi, Yu Hasegawa, et al.. (2015). ASK1 is involved in cognitive impairment caused by long-term high-fat diet feeding in mice. Scientific Reports. 5(1). 10844–10844. 20 indexed citations

16.

Hasegawa, Yu, Nobutaka Koibuchi, Kensuke Toyama, et al.. (2015). DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice. Cardiovascular Diabetology. 14(1). 54–54. 67 indexed citations

17.

Koibuchi, Nobutaka, Yu Hasegawa, Tetsuji Katayama, et al.. (2014). DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure. Cardiovascular Diabetology. 13(1). 157–157. 51 indexed citations

18.

Lin, Bo-Wen, Nobutaka Koibuchi, Yu Hasegawa, et al.. (2014). Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice. Cardiovascular Diabetology. 13(1). 148–148. 336 indexed citations breakdown →

19.

Hasegawa, Yu, Kazumichi Yamada, Ken Uekawa, et al.. (2013). Usefulness of the coherence entrainment test for deep brain stimulation for a patient with atypical tremor. Journal of Clinical Neuroscience. 20(8). 1161–1162. 1 indexed citations

20.

Uekawa, Ken, Kimio Yoshizato, Takashi Nakagawa, et al.. (2012). Influence of Antiplatelets and Anticoagulants on Prognosis of Patients with Intracerebral Hemorrhage. Surgery for Cerebral Stroke. 40(4). 233–240.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact